<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcgeriatr&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Geriatrics - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcgeriatr/</link>
        <description>The latest research articles published by BMC Geriatrics</description>
        <dc:date>2009-07-07T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/26" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/25" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/24" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/23" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/22" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/21" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/20" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/19" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/18" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/17" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/26">
        <title>Social participation and independence in activities of daily living: a cross sectional study </title>
        <description>Background:
It is today widely accepted that participation in social activities contributes towards successful ageing whilst, at the same time, maintaining independence in the activities of daily living (ADLs) is the sine qua non for achieving that end. This study looks at people aged 65 and over living in an urban area in Spain who retain the ability to attend Social Centres providing recreational facilities. The aim of this paper is to quantify independence and identify the risk factors involved in its deterioration.
Methods:
The sample size was calculated using the equation for proportions in finite populations based on a random proportional sample type, absolute error (e) = 0.05, alpha = 0.05, beta = 0.1, p = q = 0.5. Two-stage sampling was used. In the first place, the population was stratified by residence and a Social Centre was randomly chosen for each district. In the second stage, individuals were selected in a simple random sample without replacement in proportion to the number of members at each social centre.A multivariate logistical regression analysis takes functional ADL capacity as the dependent variable. The choice of predictive variables was made using a bivariate correlation matrix. Among the estimators obtained, Nagelkerke&apos;s R2 coefficient, and the Odds ratio (C.I. 95%) were considered. Sensitivity and 1-specificity were adopted to present the results in graphic form.
Results:
Out of this sample, 63.7% were fully capable of carrying out ADLs, while the main factors contributing to deterioration, identified on the basis of a logistic regression model, are in order of importance, poor physical health, poor mental health, age (above 75 years) and gender (female). The model employed has a predictive value of 88% and 92% (depending on the age range considered) with regard to the independence in ADLs.
Conclusions:
A review of the few Spanish works using similar methodology shows that the percentage of non-institutionalised persons who are independent enough to carry out ADLs is considerably lower than that found in this study of socially-active persons. Participation in recreational activities as part of a community may delay the onset of the dependence associated with ageing.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/26</link>
                <dc:creator>Encarnacion Rubio</dc:creator>
                <dc:creator>Angelina Lazaro</dc:creator>
                <dc:creator>Antonio Sanchez-Sanchez</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:26</dc:source>
        <dc:date>2009-07-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-26</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>26</prism:startingPage>
        <prism:publicationDate>2009-07-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/25">
        <title>Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-DIA CEA)</title>
        <description>Background:
Depression and elevated depression symptoms are more prevalent in patients with type 2 diabetes than in those without diabetes and are associated with adverse health outcomes and increased total healthcare utilization. There is, however, a lack of evidence on (cost-) effectiveness of treatment options for minor and mild-major depression in patients with type 2 diabetes. In this paper we describe the design and methods of the economic evaluation, which will be conducted alongside the MIND-DIA trial (Cognitive behaviour therapy in elderly type 2 diabetes patients with minor or mild-major depression). The objective of the economic evaluation (MIND-DIA CEA) is to examine incremental cost-effectiveness of a diabetes-specific cognitive behaviour group therapy (CBT) as compared to intensified treatment as usual (TAU) and to a guided self-help group intervention (SH).
Methods:
A total number of 315 patients (aged 65-85) will be included in the study and followed for 15 months. During this period data on health sector costs, patient costs and societal productivity/time costs will be collected in addition to clinical data. Person-years free of moderate/severe major depression, quality adjusted life years (QALYs), and cumulative costs will be estimated for each arm of the trial (CBT, TAU and SH). To determine cost-effectiveness of the CBT, differences in costs and effects between the CBT group and TAU/SH group will be calculated.DiscussionCBT is a potentially effective treatment option to improve quality of life and to avoid the onset of a moderate/severe major depression in elderly patients with type 2 diabetes and minor or mild-major depression. This hypothesis will be evaluated in the MIND-DIA trial. Based on these results the associated economic evaluation will provide additional evidence on the cost-effectiveness of CBT in this target population. Methodological strengths and weaknesses of the planned economic evaluation are discussed.Trial registrationThe MIND-DIA study has been registered at the Current Controlled Trials Register (ISRCTN58007098).</description>
        <link>http://www.biomedcentral.com/1471-2318/9/25</link>
                <dc:creator>Nadja Chernyak</dc:creator>
                <dc:creator>Frank Petrak</dc:creator>
                <dc:creator>Kristin Plack</dc:creator>
                <dc:creator>Martin Hautzinger</dc:creator>
                <dc:creator>Matthias Mueller</dc:creator>
                <dc:creator>Guido Giani</dc:creator>
                <dc:creator>Andrea Icks</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:25</dc:source>
        <dc:date>2009-07-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-25</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>25</prism:startingPage>
        <prism:publicationDate>2009-07-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/24">
        <title>Gender differences in the use of transportation services to community rehabilitation programs</title>
        <description>Background:
Prevention and reduction of disability among community-dwelling older adults have been an important health policy concern in Japan. Moreover, it has also become a gendered issue due to the recent rapid growth in older females than males with disability living in their own homes. The aim of this study is to examine whether there is a gender difference in the use of community rehabilitation programs in Japan, and if so, whether the lack of transportation services and accompanying caregivers are the reasons for the gender difference.
Methods:
This study was based on surveys of the program administrators and the primary caregivers of the program participants from 55 randomly selected community rehabilitation programs (CRP) in the Tokyo metropolitan area. Questions included sociodemographic characteristics of program participants, types of transportation services provided by the CRP, caregiver&apos;s relationship to participant, and the nature of family support. Bivariate statistical analysis was conducted.
Results:
Although there were more females than males with disability residing in communities, our findings showed that females were less likely to use CRP than males (1.3% and 2.3%, respectively; X2=93.0, p&lt;0.0001). Lower CRP use by females was related to lower availability of transportation services (36% without transportation service and 46% door-to-door services) and fewer caregivers accompanying the participants to CRP.
Conclusion:
This study builds on previous research findings, which suggest gender inequality in access to CRP.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/24</link>
                <dc:creator>Nanako Tamiya</dc:creator>
                <dc:creator>Li-Mei Chen</dc:creator>
                <dc:creator>Yasuki Kobayashi</dc:creator>
                <dc:creator>Mariko Kaneda</dc:creator>
                <dc:creator>Eiji Yano</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:24</dc:source>
        <dc:date>2009-06-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-24</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>24</prism:startingPage>
        <prism:publicationDate>2009-06-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/23">
        <title>Cognitive health among older adults in the United States and in England
</title>
        <description>Background:
Cognitive function is a key determinant of independence and quality of life among older adults.  Compared to adults in England, US adults have a greater prevalence of cardiovascular risk factors and disease that may lead to poorer cognitive function.  We compared cognitive performance of older adults in the US and England, and sought to identify sociodemographic and medical factors associated with differences in cognitive function between the two countries.
Methods:
Data were from the 2002 waves of the US Health and Retirement Study (HRS) (n=8,299) and the English Longitudinal Study of Ageing (ELSA) (n=5,276), nationally representative population-based studies designed to facilitate direct comparisons of health, wealth, and well-being.  There were differences in the administration of the HRS and ELSA surveys, including use of both telephone and in-person administration of the HRS compared to only in-person administration of the ELSA, and a significantly higher response rate for the HRS (87% for the HRS vs. 67% for the ELSA).   In each country, we assessed cognitive performance in non-hispanic whites aged 65 and over using the same tests of memory and orientation (0 to 24 point scale).
Results:
US adults scored significantly better than English adults on the 24-point cognitive scale (unadjusted mean: 12.8 vs. 11.4, P&lt;.001; age- and sex-adjusted: 13.2 vs. 11.7, P&lt;.001).  The US cognitive advantage was apparent even though US adults had a significantly higher prevalence of cardiovascular risk factors and disease.  In a series of OLS regression analyses that controlled for a range of sociodemographic and medical factors, higher levels of education and wealth, and lower levels of depressive symptoms, accounted for some of the US cognitive advantage.  US adults were also more likely to be taking medications for hypertension, and hypertension treatment was associated with significantly better cognitive function in the US, but not in England (P=.014 for treatment X country interaction).
Conclusions:
Despite methodological differences in the administration of the surveys in the two countries, US adults aged &gt;= 65 appeared to be cognitively healthier than English adults, even though they had a higher burden of cardiovascular risk factors and disease. Given the growing number of older adults worldwide, future cross-national studies aimed at identifying the medical and social factors that might prevent or delay cognitive decline in older adults would make important and valuable contributions to public health.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/23</link>
                <dc:creator>Kenneth Langa</dc:creator>
                <dc:creator>David Llewellyn</dc:creator>
                <dc:creator>Iain Lang</dc:creator>
                <dc:creator>David Weir</dc:creator>
                <dc:creator>Robert Wallace</dc:creator>
                <dc:creator>Mohammed Kabeto</dc:creator>
                <dc:creator>Felicia Huppert</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:23</dc:source>
        <dc:date>2009-06-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-23</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>23</prism:startingPage>
        <prism:publicationDate>2009-06-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/22">
        <title>Lewy bodies and neuronal loss in subcortical areas and disability in non-demented older people: a population based neuropathological cohort study</title>
        <description>Background:
Functional disability, the loss of ability to carry out daily tasks unaided, is a major adverse outcome more common with increasing age. The potential contribution of neuropathological changes in subcortical areas of the brain associated with normal ageing may be a contributing factor to this loss of function. This study investigates the clinicopathological relationship between functional ability during life and pathological correlates identified at post mortem in an UK population of older people (66&#8211;102 years).The aim is to examine the clinicopathological correlates of functional disability in subcortical neuronal populations of non-demented elderly individuals.
Methods:
156 non-demented participants in the brain donation programme of the Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS) were included in this study. Neuropathological examination was based on the CERAD protocol; pathologies of interest were amyloid plaques, neurofibrillary tangles, Lewy bodies, vascular disease and neuronal loss. Self-reported functional ability was scored according to a combined activities of daily living and instrumental activities of daily living scale.
Results:
Functional disability was equally common in men and women over 65 years, and in both sexes disability was more common at older ages. Neuronal loss in several subcortical regions elevated the risk of functional disability by three-fold (95% CI 1.3&#8211;6.6). There was evidence for a relationship between Lewy bodies in the SN and functional disability.
Conclusion:
Neuronal loss in subcortical regions is associated with functional disability in the older population. The causal relationships are not defined and require further investigation.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/22</link>
                <dc:creator>M Byford</dc:creator>
                <dc:creator>C Brayne</dc:creator>
                <dc:creator>I McKeith</dc:creator>
                <dc:creator>M Chatfield</dc:creator>
                <dc:creator>P Ince</dc:creator>
                <dc:creator>F Matthews</dc:creator>
                <dc:creator>MRC CFAS Neuropathology Group</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:22</dc:source>
        <dc:date>2009-06-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-22</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>22</prism:startingPage>
        <prism:publicationDate>2009-06-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/21">
        <title>Systematic care for caregivers of people with dementia in the ambulatory mental health service: designing a multicentre, cluster, randomized, controlled trial </title>
        <description>Background:
Care for people with dementia and their informal caregivers is a challenging aim in healthcare. There is an urgent need for cost-effective support programs that prevent informal caregivers of people with dementia from becoming overburdened, which might result in a delay or decrease of patient institutionalization. For this reason, we have developed the Systematic Care Program for Dementia (SCPD). The SCPD consists of an assessment of caregiver&apos;s sense of competence and suggestions on how to deal with competence deficiencies. The efficiency of the SCPD will be evaluated in our study.Methods and designIn our ongoing, cluster, randomized, single-blind, controlled trial, the participants in six mental health services in four regions of the Netherlands have been randomized per service. Professionals of the ambulatory mental health services (psychologists and social psychiatric nurses) have been randomly allocated to either the intervention group or the control group. The study population consists of community-dwelling people with dementia and their informal caregivers (patient-caregiver dyads) coming into the health service. The dyads have been clustered to the professionals. The primary outcome measure is the patient&apos;s admission to a nursing home or home for the elderly at 12 months of follow-up. This measure is the most important variable for estimating cost differences between the intervention group and the control group. The secondary outcome measure is the quality of the patient&apos;s and caregiver&apos;s lives.DiscussionA novelty in the SCPD is the pro-active and systematic approach. The focus on the caregiver&apos;s sense of competence is relevant to economical healthcare, since this sense of competence is an important determinant of delay of institutionalization of people with dementia. The SCPD might be able to facilitate this with a relatively small cost investment for caregivers&apos; support, which could result in a major decrease in costs in the management of dementia. Implementation on a national level will be started if the SCPD proves to be efficient.Trial RegistrationNCT00147693</description>
        <link>http://www.biomedcentral.com/1471-2318/9/21</link>
                <dc:creator>Anouk Spijker</dc:creator>
                <dc:creator>Frans Verhey</dc:creator>
                <dc:creator>Maud Graff</dc:creator>
                <dc:creator>Richard Grol</dc:creator>
                <dc:creator>Eddy Adang</dc:creator>
                <dc:creator>Hub Wollersheim</dc:creator>
                <dc:creator>Myrra Vernooij-Dassen</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:21</dc:source>
        <dc:date>2009-06-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-21</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2009-06-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/20">
        <title>Are sedatives and hypnotics associated with increased suicide risk in the elderly?</title>
        <description>Background:
While antidepressant-induced suicidality is a concern in younger age groups, there is mounting evidence that these drugs may reduce suicidality in the elderly. Regarding a possible association between other types of psychoactive drugs and suicide, results are inconclusive. Sedatives and hypnotics are widely prescribed to elderly persons with symptoms of depression, anxiety, and sleep disturbance. The aim of this case-control study was to determine whether specific types of psychoactive drugs were associated with suicide risk in late life, after controlling for appropriate indications.
Methods:
The study area included the city of Gothenburg and two adjacent counties (total 65+ population 210 703 at the start of the study). A case controlled study of elderly (65+) suicides was performed and close informants for 85 suicide cases (46 men, 39 women mean age 75 years) were interviewed by a psychiatrist. A population based comparison group (n = 153) was created and interviewed face-to-face. Primary care and psychiatric records were reviewed for both suicide cases and comparison subjects. All available information was used to determine past-month mental disorders in accordance with DSM-IV.
Results:
Antidepressants, antipsychotics, sedatives and hypnotics were associated with increased suicide risk in the crude analysis. After adjustment for affective and anxiety disorders neither antidepressants in general nor SSRIs showed an association with suicide. Antipsychotics had no association with suicide after adjustment for psychotic disorders. Sedative treatment was associated with an almost fourteen-fold increase of suicide risk in the crude analyses and remained an independent risk factor for suicide even after adjustment for any DSM-IV disorder. Having a current prescription for a hypnotic was associated with a four-fold increase in suicide risk in the adjusted model.
Conclusion:
Sedatives and hypnotics were both associated with increased risk for suicide after adjustment for appropriate indications. Given the extremely high prescription rates, a careful evaluation of the suicide risk should always precede prescribing a sedative or hypnotic to an elderly individual.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/20</link>
                <dc:creator>Anders Carlsten</dc:creator>
                <dc:creator>Margda Waern</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:20</dc:source>
        <dc:date>2009-06-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-20</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>20</prism:startingPage>
        <prism:publicationDate>2009-06-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/19">
        <title>A polymorphic variant of the insulin-like growth factor 1 (IGF-1) receptor correlates with male longevity in the Italian population: a genetic study and evaluation of circulating IGF-1 from the &quot;Treviso Longeva (TRELONG)&quot; study
</title>
        <description>Background:
An attenuation of the insulin-like growth factor 1 (IGF-1) signaling has been associated with elongation of the lifespan in simple metazoan organisms and in rodents. In humans, IGF-1 level has an age-related modulation with a lower concentration in the elderly, depending on hormonal and genetic factors affecting the IGF-1 receptor gene (IGF-1R).
Methods:
In an elderly population from North-eastern Italy (n = 668 subjects, age range 70&#8211;106 years) we investigated the IGF-1R polymorphism G3174A (rs2229765) and the plasma concentration of free IGF-1. Frequency distributions were compared using &#967;2-test &quot;Goodness of Fit&quot; test, and means were compared by one-way analysis of variance (ANOVA); multiple regression analysis was performed using JMP7 for SAS software (SAS Institute, USA). The limit of significance for genetic and biochemical comparison was set at &#945; = 0.05.
Results:
Males showed an age-related increase in the A-allele of rs2229765 and a change in the plasma level of IGF-1, which dropped significantly after 85 years of age (85+ group). In the male 85+ group, A/A homozygous subjects had the lowest plasma IGF-1 level. We found no clear correlation between rs2229765 genotype and IGF-1 in the females.
Conclusion:
These findings confirm the importance of the rs2229765 minor allele as a genetic predisposing factor for longevity in Italy where a sex-specific pattern for IGF-1 attenuation with ageing was found.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/19</link>
                <dc:creator>Diego Albani</dc:creator>
                <dc:creator>Sara Batelli</dc:creator>
                <dc:creator>Letizia Polito</dc:creator>
                <dc:creator>Angelica Vittori</dc:creator>
                <dc:creator>Marzia Pesaresi</dc:creator>
                <dc:creator>Giovanni Gajo</dc:creator>
                <dc:creator>Sergio De Angeli</dc:creator>
                <dc:creator>Andrea Zanardo</dc:creator>
                <dc:creator>Maurizio Gallucci</dc:creator>
                <dc:creator>Gianluigi Forloni</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:19</dc:source>
        <dc:date>2009-05-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-19</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>19</prism:startingPage>
        <prism:publicationDate>2009-05-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/18">
        <title>Psychotropic drug use among nursing home residents in Austria: a cross-sectional study</title>
        <description>Background:
The use of psychotropic medications and their adverse effects in frail elderly has been debated extensively. However, recent data from European studies show that these drugs are still frequently prescribed in nursing home residents. In Austria, prevalence data are lacking. We aimed to determine the prevalence of psychotropic medication prescription in Austrian nursing homes and to explore characteristics associated with their prescription.
Methods:
Cross-sectional study and association analysis in forty-eight out of 50 nursing homes with 1844 out of a total of 2005 residents in a defined urban-rural region in Austria. Prescribed medication was retrieved from residents&apos; charts. Psychotropic medications were coded according to the Anatomical Therapeutic Chemical Classification 2005. Cluster-adjusted multiple logistic regression analysis was performed to investigate institutional and residents&apos; characteristics associated with prescription.
Results:
Residents&apos; mean age was 81; 73% of residents were female. Mean cluster-adjusted prevalence of residents with at least one psychotropic medication was 74.6% (95% confidence interval, CI, 72.0&#8211;77.2). A total of 45.9% (95% CI 42.7&#8211;49.1) had at least one prescription of an antipsychotic medication. Two third of all antipsychotic medications were prescribed for bedtime use only. Anxiolytics were prescribed in 22.2% (95% CI 20.0&#8211;24.5), hypnotics in 13.3% (95% CI 11.3&#8211;15.4), and antidepressants in 36.8% (95% CI 34.1&#8211;39.6) of residents. None of the institutional characteristics and only few residents&apos; characteristics were significantly associated with psychotropic medication prescription. Permanent restlessness was positively associated with psychotropic medication prescription (AOR 1.54, 95% CI 1.32&#8211;1.79) whereas cognitive impairment was inversely associated (AOR 0.70, 95% CI 0.56&#8211;0.88).
Conclusion:
Frequency of psychotropic medication prescription is high in Austrian nursing homes compared to recent published data from other countries. Interventions should aim at reduction and optimisation of prescriptions.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/18</link>
                <dc:creator>Eva Mann</dc:creator>
                <dc:creator>Sascha Kopke</dc:creator>
                <dc:creator>Burkhard Haastert</dc:creator>
                <dc:creator>Kaisu Pitkala</dc:creator>
                <dc:creator>Gabriele Meyer</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:18</dc:source>
        <dc:date>2009-05-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-18</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>18</prism:startingPage>
        <prism:publicationDate>2009-05-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/17">
        <title>A 12-Year prospective study of stroke risk in older medicare beneficiaries</title>
        <description>Background:
5.8 M living Americans have experienced a stroke at some time in their lives, 780K had either their first or a recurrent stroke this year, and 150K died from strokes this year. Stroke costs about $66B annually in the US, and also results in serious, long-term disability. Therefore, it is prudent to identify all possible risk factors and their effects so that appropriate intervention points may be targeted.
Methods:
Baseline (1993&#8211;1994) interview data from the nationally representative Survey on Assets and Health Dynamics among the Oldest Old (AHEAD) were linked to 1993&#8211;2005 Medicare claims. Participants were 5,511 self-respondents &#8805; 70 years old. Two ICD9-CM case-identification approaches were used. Two approaches to stroke case-identification based on ICD9-CM codes were used, one emphasized sensitivity and the other emphasized specificity. Participants were censored at death or enrollment into managed Medicare. Baseline risk factors included sociodemographic, socioeconomic, place of residence, health behavior, disease history, and functional and cognitive status measures. A time-dependent marker reflecting post-baseline non-stroke hospitalizations was included to reflect health shocks, and sensitivity analyses were conducted to identify its peak effect. Competing risk, proportional hazards regression was used.
Results:
Post-baseline strokes occurred for 545 (9.9%; high sensitivity approach) and 374 (6.8%; high specificity approach) participants. The greatest static risks involved increased age, being widowed or never married, living in multi-story buildings, reporting a baseline history of diabetes, hypertension, or stroke, and reporting difficulty picking up a dime, refusing to answer the delayed word recall test, or having poor cognition. Risks were similar for both case-identification approaches and for recurrent and first-ever vs. only first-ever strokes. The time-dependent health shock (recent hospitalization) marker did not alter the static model effect estimates, but increased stroke risk by 200% or more.
Conclusion:
The effect of our health shock marker (a time-dependent recent hospitalization indicator) was large and did not mediate the effects of the traditional risk factors. This suggests an especially vulnerable post-hospital transition period from adverse effects associated with both their underlying health shock (the reasons for the recent hospital admission) and the consequences of their treatments.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/17</link>
                <dc:creator>Fredric Wolinsky</dc:creator>
                <dc:creator>Suzanne Bentler</dc:creator>
                <dc:creator>Elizabeth Cook</dc:creator>
                <dc:creator>Elizabeth Chrischilles</dc:creator>
                <dc:creator>Li Liu</dc:creator>
                <dc:creator>Kara Wright</dc:creator>
                <dc:creator>John Geweke</dc:creator>
                <dc:creator>Maksym Obrizan</dc:creator>
                <dc:creator>Claire Pavlik</dc:creator>
                <dc:creator>Robert Ohsfeldt</dc:creator>
                <dc:creator>Michael Jones</dc:creator>
                <dc:creator>Robert Wallace</dc:creator>
                <dc:creator>Gary Rosenthal</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:17</dc:source>
        <dc:date>2009-05-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-17</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2009-05-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
